Use of welfare benefits in multiple chemical sensitivity when compared to a general population – A registry and population-based cohort study
Multiple chemical sensitivity (MCS), characterized by adverse responses to extremely low levels of airborne chemicals, is often considered a functional somatic disorder (FSD). No standardized treatment exists and MCS individuals often cope by avoidance behaviour including adjustments in occupational...
Saved in:
| Published in: | Journal of psychosomatic research Vol. 199; p. 112431 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Elsevier Inc
01.12.2025
|
| Subjects: | |
| ISSN: | 0022-3999, 1879-1360, 1879-1360 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Multiple chemical sensitivity (MCS), characterized by adverse responses to extremely low levels of airborne chemicals, is often considered a functional somatic disorder (FSD). No standardized treatment exists and MCS individuals often cope by avoidance behaviour including adjustments in occupational life. Using Danish registry data, the aim was to investigate the use of welfare benefits in a 14-year period among Danish individuals with MCS.
Based on the Danish Study of Functional Disorders (DanFunD, 2011–2015), 177 MCS cases were identified via standardized validated questionnaires. The remaining study population without a FSD was regarded the reference as population (n = 7578). Data on welfare benefits was assessed from the Danish Register for Evaluation of Marginalization. Comparisons were made between the two groups, 10 years retrospectively, and 4 years prospectively from participation in DanFunD. A secondary comparison group was individuals with type 2 diabetes.
Retrospectively, a higher proportion of individuals with MCS received sickness benefit (29 % vs 48 %, p < 0.05), disability pension (2 % vs 14 %, p < 0.05), and unemployment benefits (21 % vs 29 %, p < 0.05). 4 years prospectively, individuals with MCS had a higher relative risk (RR) of disability pension (RR: 2.73, 95 % CI 1.45, 5.16). Similar differences were seen when comparing with type 2 diabetes individuals.
During a 14-year period, compared to the general population, use of welfare benefits was higher in individuals with MCS primarily due to increased sickness leave and work disability. MCS has substantial influence on the individuals' occupational situation and is potentially a high burden on society.
•Knowledge on the consequences on society in terms of use of welfare benefits in MCS is lacking.•This study utilized Danish registry data to explore use of welfare benefits in MCS.•Individuals with MCS displayed significantly more welfare benefits than those without. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ISSN: | 0022-3999 1879-1360 1879-1360 |
| DOI: | 10.1016/j.jpsychores.2025.112431 |